2019-02-14T15:56:29-06:00 2018-03-31 GRANT THORNTON LLP 100 E WISCONSIN AVE MILWAUKEE WI 53202 990 2017-04-01 731008735 Oklahoma Blood Institute % RANDALL STARK OKLA 4052975700 1001 North Lincoln Blvd Oklahoma City OK 73104 RANDALL STARK CFO/TREASURER 4052975700 2019-02-14 true MICHELLE L WEBER P00556798 4142898200 2019-02-12 209.220.64.52 73466320190455000001 2019-02-14 P EE0445AAFC7BCEACA6A025D08834C35C00D758E8 57486736AB26ACA834109ECA141AD894F423C384 2017 2019-02-21 02:37:17Z Randall Stark 1001 North Lincoln Blvd Oklahoma City OK 73104 103655220 false X www.obi.org X 1977 OK TO BE THE DONOR-TO-PATIENT LIFELINES; PROVIDING OUR COMMUNITIES AND MEDICAL PARTNERS SECURITY BY MEETING BLOOD TRANSFUSION AND HEALTH CARE NEEDS 27 22 1097 3578 43851 0 1217426 521325 94414087 101675799 54960 45281 1045766 1137169 96732239 103379574 0 230896 0 0 49210812 52718501 0 0 166736 46403423 48659532 95614235 101608929 1118004 1770645 61288816 66891279 20559694 24379279 40729122 42512000 X OKLAHOMA BLOOD INSTITUTE'S (OBI'S) MISSION IS TO BE THE DONOR-TO-PATIENT LIFELINES BY PROVIDING OUR COMMUNITIES AND MEDICAL PARTNERS SECURITY BY MEETING BLOOD TRANSFUSION AND HEALTH CARE NEEDS. FOR THE FISCAL YEAR ENDED MARCH 31, 2018, OBI MANAGED THE LIFE-SAVING BLOOD DONATIONS OF 206,726 PEOPLE IN THE REGION. OF THESE DONATIONS, 338,468 UNITS OF BLOOD WERE DELIVERED TO PATIENTS IN 235 HOSPITALS AND AIR AMBULANCE SERVICES ACROSS THE REGION. PRIOR TO RECEIVING DONATIONS AND PROVIDING TRANSFUSIONS, OBI HAD TO UNDERGO AN IMMENSE AMOUNT OF FDA- REGULATED PROCESSING AND TESTING FOR DONOR AND BLOOD RECIPIENT SAFETY. VOLUNTEER BLOOD DONORS GIVE WHAT CANNOT BE CREATED AND PROVIDED FROM ANY OTHER MEANS. OBI RECRUITS DONORS, PROVIDES SKILLED MEDICAL STAFF, TECHNOLOGY AND FACILITIES TO COLLECT BLOOD FROM DONORS. LAB PROFESSIONALS UNDER THE MEDICAL SUPERVISION OF PHYSICIANS PREPARE THE BLOOD FOR TRANSFUSION AND ADMINISTER 15 SAFETY TESTS. ALL MUST BE DONE WITH UTMOST URGENCY AND AROUND THE CLOCK, false false 84572224 90626564 AS THE SIXTH-LARGEST BLOOD CENTER IN THE U.S., OBI MANAGED 258,692 LIFE-SAVING BLOOD DONATIONS IN THE REGION DURING FISCAL YEAR 2018. OUR COMPLEX TECHNOLOGICAL INFRASTRUCTURE AND RARE MEDICAL EXPERTISE ALLOWS OBI TO PROVIDE SAFE AND ADEQUATE BLOOD TO PATIENTS IN AREA HOSPITALS. OUR RIGOROUS SAFETY MEASURES AND THE TIRELESS EFFORTS OF OUR MEDICAL LABORATORY STAFF ENSURE THAT THE DONATED BLOOD IS SAFE AND AVAILABLE TO SAVE LIVES. SEE SCHEDULE O FOR MORE INFORMATION ON THE SCOPE OF THIS EXTENSIVE OPERATION OR VISIT OBI.ORG. 7310449 7310449 OBI'S TESTING LABORATORY IS AMONG THE MOST ADVANCED IN THE NATION. OBI LABORATORY SERVICES ENSURE A SAFE BLOOD SUPPLY FOR THE MEDICAL PROVIDERS WE SUPPLY. ADDITIONALLY, WE WORK HAND-IN-HAND TO ASSIST OTHER BLOOD CENTERS, CLINICS AND ORGAN DONATION ORGANIZATIONS. OUR LABORATORY'S CUTTING-EDGE TECHNOLOGY PROVIDES OUR CLIENTS WITH THE IMPECCABLY-EFFICIENT TURNAROUND REQUIRED FOR HIGHLY-SPECIALIZED BLOOD TESTING. MAINTAINING STRICT AABB-ACCREDITATION AND FDA-LICENSING STANDARDS, OUR LAB PROVIDES NUCLEIC ACID TESTING AND SEROLOGICAL AND VIRAL MARKER SCREENING TESTS, INCLUDING A WIDE RANGE OF SCREENING ASSAYS. CONFIRMATORY/SUPPLEMENTAL ASSAYS AND REFERRAL TESTING SERVICES ARE ALSO OFFERED. FOR MORE INFORMATION, VISIT OBI.ORG/MEDICAL-PROFESSIONALS/LAB-TESTING-SERVICES. 2043248 2664977 THERAPEUTIC APHERESIS SERVICES FOR PATIENTS AT AREA HOSPITALS ARE PROVIDED BY SPECIALLY-TRAINED REGISTERED NURSES UNDER THE DIRECTION OF TRANSFUSION MEDICINE PHYSICIANS. PATIENTS UNDERGO TREATMENTS THAT REMOVE HARMFUL PROTEINS, CHEMICALS OR CELLS IN THE BLOOD THAT CONTRIBUTE TO A VARIETY OF LIFE-THREATENING DISEASES OR TRANSPLANT COMPLICATIONS. BASED ON PATIENTS' CONDITIONS, SPECIFIC OFFENDING AGENTS OR COMPONENTS OF THE BLOOD ARE ISOLATED AND IRRADIATED OR REMOVED. AFTER THIS INTRICATE PROCESSING, PATIENTS RECEIVE THEIR TREATED BLOOD TO RESTORE HEALTH. FOR MORE INFO, VISIT OBI.ORG/ABOUT-US/THERAPEUTIC-PHLEBOTOMY. 1228771 230896 882586 MISCELLANEOUS 618703 116640 CELL THERAPY 386013 665847 BLOOD PRODUCT DERIVATIVES 2233487 230896 1665073 96159408 true true false true false false false false false false true false false false false true false true false false false false false false false false false true false true false false false false false false true false false false false false true true true false false false true 87 0 true 1097 true true true false false false false false false false false false X 27 22 false false false false true true false true true false false true true true true true true true true false OK X RANDALL STARK 4052975700 1001 NORTH LINCOLN BLVD Oklahoma City OK 73104 JOHN B ARMITAGE MD President/CEO/Medical Director 50.0 9.0 X X 559539 0 65125 Richard Boatsman MD Chair 3.0 5.0 X X 0 0 0 David R Carpenter Vice-Chair 3.0 0.0 X X 0 0 0 John Adams Board Member 1.0 0.0 X 2000 0 0 Frank Barnett MD Board Member 1.0 0.0 X 0 0 0 John Bridwell Board Member 1.0 0.0 X 0 0 0 Larry Bookman MD Board Member 1.0 0.0 X 12000 0 0 Scott Calhoon MD Board Member 1.0 0.0 X 500 0 0 Jennifer Holter-Chakrabarty MD Board Member 1.0 0.0 X 0 0 0 Sam Dahr MD Board Member - As of 01/18 1.0 0.0 X 0 0 0 David A Flack MD Board Member 1.0 0.0 X 0 0 0 Jay Allen Gregory MD Board Member 1.0 0.0 X 0 0 0 W John Hefner Board Member 1.0 1.0 X 0 0 0 Joe M Hodges Board Member 2.0 0.0 X 2000 0 0 David Holden MD Board Member 1.0 0.0 X 0 0 0 Henry J Hood Board Member 1.0 0.0 X 12000 0 0 Randal C Juengel MD Board Member 4.0 4.0 X 12000 0 0 R Kordestain MD Board Member 1.0 0.0 X 0 0 0 WH Oehlert MD Board Member 1.0 0.0 X 0 0 0 Judy Goforth Parker PHD RN Board Member 1.0 0.0 X 0 0 0 Gary L Patzkowsky DO Board Member 1.0 0.0 X 0 0 0 Myron Pope EDD Board Member 1.0 0.0 X 0 0 0 Paul Stout MD Board Member 1.0 0.0 X 0 0 0 Evan Vincent Board Member 1.0 0.0 X 12000 0 0 Kristi Weaber Board Member 1.0 0.0 X 0 0 0 Don L Wilber MD BOARD MEMBER - THRU 12/17 1.0 0.0 X 0 0 0 Garland Wilkinson Board Member 1.0 0.0 X 0 0 0 Phyllis Worley Board Member 1.0 0.0 X 0 0 0 James W Smith MD PhD Chief Medical Officer 50.0 0.0 X 282003 0 21448 Randall Stark CFO/Treasurer 50.0 7.0 X 231819 0 27305 Kim J Van Antwerpen VP, Technical Operations 50.0 0.0 X 193932 0 40370 Mark E Patterson VP, Finance & Corp. Develop. 50.0 3.0 X 179787 0 32386 CHARLES MOONEY JR VP,QUALITY MGMT & NEW VENTURE 50.0 0.0 X 177065 0 52508 Regina Gardner VP, Donor Services 50.0 0.0 X 175911 0 10790 Terry Ridenour VP, Sub-Center Operations 50.0 0.0 X 169960 0 21834 Jerry E Potter Chief Information Officer 50.0 0.0 X 158361 0 18746 Daren Coats VP, Western Operations 50.0 0.0 X 155946 0 12756 TAMARA J WHITELEY VP, COMMUNITY RELATIONS 50.0 0.0 X 150882 0 36815 MICHAEL STEVENSON MD MEDICAL DIRECTOR 50.0 0.0 X 207934 0 11546 DEBRA SMITH MD PHD MEDICAL DIRECTOR 50.0 0.0 X 189725 0 19451 JOSEPH R MCNEIL Director of H.R. 50.0 0.0 X 142078 0 23039 PAM KELLY DIRECTOR OF I.T. APPLICATIONS 50.0 0.0 X 139270 0 10026 GARY J LYNCH SUSTAINABILITY OFFICER 50.0 0.0 X 131675 0 21009 3298387 0 425154 34 false true false HEALTHSMART BENEFIT SOLUTIONS PO BOX 207463 DALLAS TX 753207463 BENEFITS ADMIN 1369760 NABHOLZ CONSTRUCTION 1718 ALDERSGATE ROAD LITTLE ROCK AR 72205 CONSTRUCTION MGMT 601588 PEAK MEDIA LLC 6016 NW 154TH STREET EDMOND OK 73013 ADVERTISING BUYER 298013 ONESOURCE MANAGED SERVICES PO BOX 270538 OKLAHOMA CITY OK 731370538 MANAGED PRINT SVC 273475 LEVEL 3 COMMUNICATIONS LLC PO BOX 910182 DENVER CO 802910182 TELECOMMUNICATIONS 267836 11 60000 461325 8495 521325 SERVICE FEES 900099 84906704 84906704 LABORATORY FEES 621990 7310449 7304897 5552 FURTHERED MANUFACTURED PLASMA FEES 900099 5719860 5719860 PATIENT CARE SERVICES FEES 900099 2664977 2664977 DERIVATIVES 900099 665847 665847 407962 407962 101675799 26248 26248 0 0 313478 275179 38299 0 38299 38299 19500 467 19033 19033 19033 0 0 0 0 0 0 0 0 0 CONTACT CENTER 900099 277316 277316 PATRONAGE DIVIDENDS 900099 238838 238838 REBATES 900099 223011 161535 61476 359705 152413 207292 1098870 103379574 102261511 43851 552887 230896 230896 0 0 0 2969302 2257255 712047 29373 29373 39481116 37044495 2301075 135546 660946 605810 52407 2729 6716277 5826892 886579 2806 2861487 2649242 203108 9137 0 246464 246464 111136 111136 16667 16667 0 32893 32893 799186 675653 123533 614606 614606 721697 653022 67516 1159 965393 965393 0 2928641 2928641 545752 474471 68203 3078 0 183252 93075 89988 189 0 321370 321370 5046661 4839811 203642 3208 214698 195642 19056 SUPPLIES 26716069 26716050 19 EQUIPMENT REPAIR 2237976 2221721 8739 7516 MOTOR VEHICLES 1904524 1843360 61164 DONOR RECOGNITION 1149476 1147679 1797 3903071 3824951 76752 1368 101608929 96159408 5282785 166736 1935 1967 9501910 9546241 0 0 12825901 15799874 0 0 0 0 0 0 3885230 4333328 1467413 1268446 59836864 31483056 29712315 28353808 0 0 0 0 0 0 933590 4513179 2960522 3074436 61288816 66891279 10928872 15673871 0 0 1000000 714286 0 0 0 0 0 0 8630822 7991122 0 0 0 0 20559694 24379279 X 40729122 42512000 0 0 0 0 40729122 42512000 61288816 66891279 X 1770645 -30890 43123 X false true X true false X 1037397 919214 3781621 1217426 521325 7476983 82642403 83428991 83559096 94414087 102261511 446306088 0 0 0 83679800 84348205 87340717 95631513 102782836 453783071 0 39027252 27780889 38730899 37524656 43797108 186860804 39027252 27780889 38730899 37524656 43797108 186860804 266922267 367561 386358 359754 382625 26248 1522546 0 367561 386358 359754 382625 26248 1522546 0 904676 639198 476206 693755 507606 3221441 84952037 85373761 88176677 96707893 103316690 458527058 0.58213 0.56645 0.00332 0.00404 X false false false false false false true 16667 false 16667 DIRECT CONTACT WITH LEGISLATORS SCHEDULE C, PART II-B, LINE 1G ESTABLISHMENT OF A PUBLIC UMBILICAL CORD BLOOD PROGRAM AS A MAJOR HEALTH ADVANCEMENT FOR OKLAHOMA REQUIRED EDUCATION AND ADVOCACY EFFORTS WITH STATE LEGISLATORS. LOBBYING EXPENSES WERE INCURRED AS A RESULT. AS ONLY THE 25TH SUCH CORD BLOOD PROGRAM IN THE WORLD, IT FILLS A CRITICAL NEED FOR UMBILICAL CORD-HARVESTED STEM CELLS THAT CAN BE LIFE-SAVING FOR PATIENTS WITH NO OTHER HOPE OTHER THAN A STEM CELL TRANSPLANT. WITHOUT AN OKLAHOMA CENTER AT OBI, MINORITY POPULATIONS MOST PREVALENT IN OKLAHOMA WOULD REMAIN POORLY REPRESENTED WITHIN NATIONAL REGISTRIES. OBI WAS THE ONLY ORGANIZATION IN OKLAHOMA WHERE REQUIRED CORE BLOOD PROCESSING AND TESTING TECHNOLOGY AND EXPERTISE EXISTED. HOWEVER, EXTENSIVE, ONGOING FUNDING IS REQUIRED FOR MORE SOPHISTICATED TECHNOLOGY AND EXPERTISE TO SUPPORT SUCH A WORLD-CLASS PROGRAM. FOR MORE INFORMATION, VISIT OBI.ORG/ABOUT-US/CORD-BLOOD-BANK. 683594 683594 16839618 7370933 9448685 17648161 9165416 8482745 18524843 11479322 7045521 6160648 3467385 2693263 28353808 0 0 X LIABILITY FOR UNCERTAIN TAX POSITION (ASC 740) SCHEDULE D, PART X, LINE 2 Holding, the Institute, OBI Real Estate Company, OBI Real Estate Company 2, Global Blood Fund and the Foundation are not-for-profit corporations as described in the Internal Revenue Code and are exempt from federal income taxes on related income pursuant to Section 501(a) of the Code. The Company generates unrelated business income through certain testing and debt-financed leasing activities, the taxes on which have historically been inconsequential and are included in the allocated expenses reported in the combined statements of activities. Management has reviewed the Company's tax positions and concluded that there are no uncertain tax positions that meet the more-likely-than-not criteria that would require accrual in the financial statements or disclosure in the footnotes to be in compliance with authoritative guidance. Generally, the Company is no longer subject to income tax examinations by federal, state or local tax authorities for years before 2014. true GLOBAL BLOOD FUND 1001 N Lincoln Blvd Oklahoma City OK 73104 392071848 501(c)(3) 158945 0 Support Mission BRIDGE BUILDERS FOR THE CROSS INC PO Box 2623 Ada OK 74821 203020382 501(c)(3) 12704 FMV T-Shirts Event Sponsorship GREATER OKLAHOMA CITY CHAMBER OF COMMERCE 123 Park Ave Oklahoma City OK 73105 730381180 501(c)(6) 11250 0 Forward OKC Program CHILDREN'S HOSPITAL FDN AT SAINT FRANCIS 6161 South Yale Ave Tulsa OK 74136 202843418 501(c)(3) 10000 0 Event Sponsorship INTEGRIS HEALTH FOUNDATION INC 3030 NW Expressway Oklahoma City OK 73122 731047338 501(c)(3) 6500 0 Event Sponsorship 4 1 MONITORING THE USE OF GRANT FUNDS IN THE U.S. SCHEDULE I, PART I, LINE 2 Global Blood Fund: This charity (of which OBI is the sole member) has a mission to improve transfusion care in the developing world. This is considered a natural extension of OBIs purpose to save patient lives through blood products provided in our local settings. The OBI Executive Committee and entire Board of Directors both reviewed and approved this contribution in advance. Bridge Builders for the Cross: This Oklahoma charity deployed surplus OBI t-shirts (acquired for now ended promotional campaigns) in Mexico to encourage engagement in community strengthening activities. Greater Oklahoma City Chamber of Commerce: This contribution supported efforts to advance civic progress, most relevantly the growth and development of the Innovation District which is intended to elevate the work space and business climate in and around the location of OBIs main operational and employment locations. Childrens Hospital Foundation: This contribution reflects inter-institutional piloting of partnership activities related to blood donor recruitment and optimal transfusion care. Integris Health Foundation: This contribution reflects inter-institutional piloting of partnership activities related to blood donor recruitment and optimal transfusion care. X X X false false false false false false false true false JOHN B ARMITAGE MD President/CEO/Medical Director 486864 0 50175 0 22500 0 16500 0 48625 0 624664 0 0 0 James W Smith MD PhD Chief Medical Officer 254805 0 75 0 27123 0 5500 0 15948 0 303451 0 0 0 Randall Stark CFO/Treasurer 216544 0 5275 0 10000 0 4817 0 22488 0 259124 0 0 0 Kim J Van Antwerpen VP, Technical Operations 179357 0 7075 0 7500 0 4025 0 36345 0 234302 0 0 0 Mark E Patterson VP, Finance & Corp. Develop. 172212 0 75 0 7500 0 3747 0 28639 0 212173 0 0 0 CHARLES MOONEY JR VP,QUALITY MGMT & NEW VENTURE 169490 0 75 0 7500 0 3912 0 48596 0 229573 0 0 0 Regina Gardner VP, Donor Services 168236 0 175 0 7500 0 3570 0 7220 0 186701 0 0 0 Terry Ridenour VP, Sub-Center Operations 155385 0 7075 0 7500 0 3494 0 18340 0 191794 0 0 0 Jerry E Potter Chief Information Officer 150736 0 125 0 7500 0 3261 0 15485 0 177107 0 0 0 Daren Coats VP, Western Operations 146763 0 75 0 9108 0 3216 0 9540 0 168702 0 0 0 TAMARA J WHITELEY VP, COMMUNITY RELATIONS 143107 0 275 0 7500 0 3237 0 33578 0 187697 0 0 0 MICHAEL STEVENSON MD MEDICAL DIRECTOR 200359 0 75 0 7500 0 4187 0 7359 0 219480 0 0 0 DEBRA SMITH MD PHD MEDICAL DIRECTOR 182150 0 75 0 7500 0 3888 0 15563 0 209176 0 0 0 JOSEPH R MCNEIL Director of H.R. 141503 0 575 0 0 0 3013 0 20026 0 165117 0 0 0 GARY J LYNCH SUSTAINABILITY OFFICER 131500 0 175 0 0 0 2729 0 18280 0 152684 0 0 0 Nonfixed Payments Schedule J, Part I, Line 7 THE CEO HAS THE POTENTIAL OF EARNING A BONUS BASED ON CEO PERFORMANCE CRITERIA, REGULATORY COMPLIANCE, ORGANIZATIONAL GROWTH, MAINTAINING CUSTOMERS, ACQUIRING NEW CUSTOMERS, CUSTOMER SERVICE, PUBLIC PERCEPTION, AND ALLOWING NO SHORTAGE OF BLOOD PRODUCTS TO HOSPITAL CUSTOMERS. TINA COATS WIFE OF OFFICER 118774 SALARY 108,936 BENEFITS 9,838 false MARTA PATTERSON WIFE OF OFFICER 102809 SALARY 85,036 BENEFITS 17,773 false CATHERINE ARMITAGE WIFE OF OFFICER 29373 SALARY 29,306 BENEFITS 67 false BUSINESS TRANSACTIONS INVOLVING INTERESTED PERSONS SCHEDULE L, PART IV THE ABOVE BUSINESS TRANSACTIONS INVOLVING INTERESTED PERSONS ARE PROVIDED TO OBI AT OR BELOW FAIR VALUE AND ARE IN THE NORMAL COURSE OF BUSINESS. ALL DECISIONS TO ENTER INTO THESE TRANSACTIONS WERE REVIEWED IN ACCORDANCE WITH OUR CONFLICT OF INTEREST POLICY AND THE INTERESTED PERSONS WERE EXCLUDED FROM THE DECISION MAKING PROCESS. TINA COATS: SHE WAS EMPLOYED IN A DEPARTMENT (DONOR SERVICES) OUTSIDE THE HIRING AND REPORTING RESPONSIBILITIES OF HER HUSBAND, DAREN COATS (WESTERN OPERATIONS). EXECUTIVE MANAGEMENT WAS AWARE OF THE RELATIONSHIP AND FOUND NO GOVERNANCE CONCERNS WITH MRS. COATS' CANDIDACY AND HIRING. MARTA PATTERSON: SHE WAS HIRED BY OBI PRIOR TO ESTABLISHING A RELATIONSHIP WITH MARK PATTERSON. SHE WAS EMPLOYED IN A DEPARTMENT (QUALITY MANAGEMENT) OUTSIDE THE REPORTING RESPONSIBILITY OF HER HUSBAND (FINANCE AND CORPORATE DEVELOPMENT). CATHERINE ARMITAGE: SHE WAS EMPLOYED TO DO CONTRACT WORK FOR GLOBAL BLOOD FUND THAT WAS ENTIRELY SUPPORTED FINANCIALLY BY A GRANT FROM AN OUTSIDE ORGANIZATION. THE OBI EXECUTIVE COMMITTEE AND ENTIRE BOARD OF DIRECTORS WERE BOTH AWARE OF THE RELATIONSHIP AND FOUND NO GOVERNANCE CONCERNS WITH MRS. ARMITAGE'S CANDIDACY AND HIRING. PROGRAM SERVICE ACCOMPLISHMENTS FORM 990, PART III, LINE 4D EXPENSES: $618,703 GRANTS: REVENUE: $116,640 THE CELL THERAPY PROGRAM IS INVOLVED WITH COLLECTIONS OF STEM CELLS AND CORD BLOOD FROM PATIENTS, TESTING AND MANUFACTURING THE PRODUCTS FOR PATIENT USES. EXPENSES: $386,013 GRANTS: REVENUE: $665,847 DERIVATIVES ARE A PRODUCT MANUFACTURED FROM A RAW MATERIAL BYPRODUCT OF BLOOD COLLECTION. OBI COLLECTS THIS MATERIAL, WHICH IS UNUSABLE FOR BLOOD TRANSFUSION, AND DISTRIBUTES THIS BYPRODUCT TO PLASMA MANUFACTURERS WHICH, IN TURN, USE IT IN THE PRODUCTION OF A BIOLOGICAL DRUG. EXPENSES: $1,228,771 GRANTS: $230,896 REVENUE: $882,586 OTHER MISCELLANEOUS REVENUE COMES FROM OTHER SOURCES DIRECTLY RELATED TO THE TAX-EXEMPT PURPOSE OF THE ORGANIZATION SUCH AS CONSULTING AND DEVELOPMENT PROVIDED TO OTHER NONPROFIT BLOOD CENTERS. EXECUTIVE COMMITTEE FORM 990, PART VI, LINE 1 The members of the board of directors of the OBI holding company shall also comprise the executive committee of the corporation, and shall consist of the chairperson, vice chairperson, president and four other members of the board of directors elected by a vote of the board. The executive committee shall be responsible for the management of all funds of the corporation, shall have authority to supervise, manage and direct all business affairs of the corporation and shall also determine the non-medical policies of the corporation, subject to approval of the board of directors. MEMBERS OF THE ORGANIZATION FORM 990, PART VI, LINES 6 & 7A OBI's bylaws provide for a single member, OBI Holding Company, and the single member has the authority to appoint Board Members. The Single Member's board is elected by the Board of OBI, and their actions are subject to OBI's approval. FORM 990 REVIEW FORM 990, PART VI, LINE 11B OBI has the annual IRS foRm 990 reviewed by the audit committee of the Board of Directors in a joint meeting with the company's external auditors prior to filing. The committee receives a copy of the form 990 prior to the meeting and key sections on governance, policies, compensation and program expense are reviewed. The review is completed and the meeting is documented within the minutes, which becomes part of both committees' permanent files. At the conclusion of the review, the entire board is provided a copy of the form 990 prior to filing. CONFLICT OF INTEREST POLICY Form 990, Part VI, LINE 12c OBI's conflict of interest policy is provided to all Board members and Officers on an annual basis and they are required to sign annual conflict of interest and confidentiality statements each year. Executed copies of the conflict of interest and confidentiality statements are maintained in the corporate records and the Chair of the Audit/Risk Management Committee and Executive Committee are informed of any conflicts disclosed. If a conflict does exist, the member would recuse themselves from any votes or discussions related to the area of conflict. OBI maintains a confidential disclosure hot line and website that allows employees to anonymously report any concerns or potential conflicts of interest. All reports are sent through the senior H.R. employee, and significant issues are forwarded to the Chair of the Audit/Risk Management Committee. COMPENSATION REVIEW Form 990, Part VI, LINES 15a & 15b As leaders of the states largest biopharmaceutical organization, a 880-plus staff entity, the roles of CEO and other physicians and executives require a rare blend of astute organizational leadership, vision, fiduciary management, advanced medical specialization and expertise in the unique scientific field of transfusion medicine. Executives have responsibility for 14 operational facilities across 10 major markets in the region and the day-to-day provision of a safe and sufficient blood supply to meet the needs of patients in more than 200 hospitals served. The compensation of the CEO is determined by the Executive Committee of the Board of Directors comprising of community leaders, business executives and physicians with exemplary ethical and fiduciary standards. CEO compensation is based on comparative salary data from similar health care organizations using IRS Form 990 and industry salary surveys. Similarly, compensation for executives reporting to the CEO is proposed by the CEO based on comparable national and local salaries for positions and is approved by the Executive Comittee. Changes to compensation are reviewed and formally approved by the Executive Committee of the Board of Directors. AVAILABILITY OF FORMS AND GOVERNING DOCUMENTS Form 990, Part VI, LINES 18 & 19 Copies of the organization's form 990 and 990-T are available to the public upon request. Conflict of interest and financial statements are available upon request. OTHER CHANGES IN NET ASSETS AND FUND BALANCES FORM 990, PART XI, LINE 9 CASH VALUE OF LIFE INSURANCE 43,122 OKLAHOMA BLOOD INSTITUTE REAL ESTATE 1001 NORTH LINCOLN BLVD OKLAHOMA CITY OK 73104 731386856 REAL ESTATE OK 0 0 OBI OBI REAL ESTATE COMPANY 2 1001 NORTH LINCOLN BLVD OKLAHOMA CITY OK 73104 731386765 REAL ESTATE OK 0 0 OBI OBI VENTURES LLC 1001 NORTH LINCOLN BLVD OKLAHOMA CITY OK 73104 731349219 INVESTMENTS OK 0 0 OBI OKLAHOMA BLOOD INSTITUTE FOUNDATION 1001 north lincoln blvd Oklahoma City OK 73104 311721750 SUPPORT ORG OK 501(C)(3) 12-II OBIHC false OBI HOLDING COMPANY 1001 north lincoln blvd Oklahoma City OK 73104 731386765 HOLDING CO OK 501(C)(3) 10 NA false GLOBAL BLOOD FUND 1001 north lincoln blvd Oklahoma City OK 73104 392071848 BLOOD SVCS OK 501(C)(3) 07 OBIHC false ALLIANCE FOR COMMUNITY TRANSFUSION SRV 2205 HIGHWAY 121 BEDFORD TX 76021 454624346 EFFICIENCY TX 501(C)(3) 12-II NA false false true true false false false false false false false false false true true true false false false false